Bristol Myers Squibb
Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, is headquartered in the United Arab Emirates (AE) and operates extensively across North America, Europe, and Asia. Founded in 1887, BMS has a rich history marked by significant milestones in drug development and innovation.
Specialising in oncology, immunology, cardiovascular diseases, and fibrosis, Bristol Myers Squibb is renowned for its unique portfolio of therapies, including groundbreaking treatments like Opdivo and Eliquis. These products are distinguished by their advanced mechanisms of action and proven efficacy, positioning BMS as a frontrunner in the pharmaceutical industry.
With a commitment to research and development, Bristol Myers Squibb has achieved notable recognition, consistently ranking among the top biopharmaceutical companies globally. Its dedication to improving patient outcomes underscores its pivotal role in transforming healthcare.
+11 vs industry average
Bristol Myers Squibb’s score of 46 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Bristol Myers Squibb?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Retail Trade Services has below-average carbon intensity
Industry performance
The Retail Trade Services industry has reduced its overall emissions by 42% since 2019
Emissions trajectory 2020 – 2023
Reported emissions
Scope 3 accounts for ••• of total emissions.
Bristol Myers Squibb's reported carbon emissions
In 2020, Bristol Myers Squibb reported total carbon emissions of approximately 289,930 kg CO2e. This figure includes 165,340 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 112,700 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, the company recorded 11,890 kg CO2e in Scope 3 emissions, specifically from business travel. Comparatively, emissions in previous years were higher, with 339,880 kg CO2e in 2019 and 375,360 kg CO2e in 2018. This indicates a significant reduction in total emissions over the two-year period, showcasing Bristol Myers Squibb's commitment to lowering its carbon footprint. Despite these reductions, there are currently no specific science-based targets (SBTi) or documented climate pledges outlined in their initiatives. The emissions data is cascaded from the parent company, Bristol-Myers Squibb Company, reflecting the company's ongoing efforts to address climate change within its operational framework. Bristol Myers Squibb continues to focus on sustainability and environmental responsibility, aligning with industry standards for climate action.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Bristol Myers Squibb’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Bristol Myers Squibb yet.
Scope 3 top emissions categories
1 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative
Inherited from Bristol-Myers Squibb Company
Carbon Disclosure Project
Inherited from Bristol-Myers Squibb CompanyThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Bristol-Myers Squibb CompanyRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project